Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents

Author(s): S. G. Buchanan, J. M. Sauder and T. Harris

Volume 8, Issue 13, 2002

Page: [1173 - 1188] Pages: 16

DOI: 10.2174/1381612023394809

Price: $65

Abstract

Structural Genomics stands out among the emerging fields of proteomics since it influences the drug discovery process at so many points. Recent developments in protein expression technologies, x-ray crystallography and NMR spectroscopy provide the essential elements for high-throughput structure determination platforms. Bioinformatics methods to interrogate the resulting data will provide comprehensive, genome-wide databases of protein structure. Genomic sequencing and methods for high-throughput expression and protein purification are furthest advanced for microbial genes and so these have been the early targets for structural genomics initiatives. The information will be invaluable in understanding gene function, designing broad-spectrum small molecule inhibitors and in better understanding drug-host interactions.

Keywords: structural genomics, antimicrobial agents, proteomics


Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy
?>